BGM Group Ltd. (BGM) company profile
Close on Nov 17, 2026Market cap $3.26BP/E –Yield –
About BGM
Pharmaceutical Preparations, SIC 2834
BGM Group Ltd is a holding company that conducts its business activities in China through contractual variable interest entity arrangements. The operating business primarily develops, manufactures, markets, and sells traditional Chinese medicine products and pieces, alongside operating a sausage casings business. Additionally, its enterprise network encompasses technology services, management consulting, and electronic commerce services. The group directs its offerings to consumers and commercial purchasers in the healthcare, pharmaceutical, food processing, and related commercial markets.
The company operates primarily across the People's Republic of China, maintaining functional subsidiaries and facilities in locations such as Jiuquan in Gansu Province, Chengdu and Sichuan Province, Jiangsu Province, Hainan, Shenzhen, and Beijing, with overseas corporate entities organized in Hong Kong and the British Virgin Islands. BGM Group Ltd maintains its corporate holding company headquarters and legal incorporation in the Cayman Islands.
Summary of the business section of BGM's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BGM Group Ltd.
- Founded
- 1969
- Headquarters
- Chengdu, China
- Address
- No. 152 Hongliang East 1st Street, No. 1703, Tianfu New District 0000
- Phone
- 86-028-64775180
- Employees
- 206, Sep 30, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- E9
- Fiscal year ends
- September 30
- Auditor
- ZH CPA, LLC, Denver, Colorado
Stock & identifiers
- Ticker
- BGM
- Former tickers
- QLI until Jan 27, 2025
- Exchange
- Nasdaq
- IPO date
- Jan 12, 2021
- Shares outstanding
- 401M, Sep 30, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-30 reverse, Oct 1, 2026; 1-for-5 reverse, Jun 21, 2024
- SEC CIK
- 1779578
- CUSIP
- G7307E123
- FIGI
- BBG00QRWPVY9
- Share class FIGI
- BBG00QRWPWR5
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yaxuan ZHAI | Chief Financial Officer | – |
| yuehua ren | Director | – |
| Waihua Xu | Director | – |
| Zefei Lou | Director | – |
| LIN (Henry) ZHANG | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Jan 12, 2021
- Offer price
- $5.00
- Exchange
- Nasdaq
- First trading day
- Jan 12, 2021
- First-day close
- $10.00+100.0%
- Lock-up ends (est.)
- Jul 11, 2021
“PER SHARE TOTAL (4) Initial public offering price (1) $ 5.00 $ 25,000,000 Underwriting discounts (2) $ 0.35 $ 1,750,000 Proceeds, before expenses, to us (3) $ 4.65 $ 23,250,000 (1) Initial public offering price per share is $5.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“The following table sets forth a breakdown of employees by activity in Jiuquan City and Qionglai City for Gansu QLS, Moshangfa and Chengdu QLS as of September 30, 2025: … Total 206”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 30, 2026 | Late filing | Notification of late filing |
| Oct 22, 2024 | Name change | Name changed from Qilian International Holding Group to BGM Group Ltd. |
| Oct 16, 2024 | Name change | Name changed from Qilian International Holding Group Ltd to Qilian International Holding Group |
| Feb 1, 2024 | Late filing | Notification of late filing |
| Jan 31, 2023 | Late filing | Notification of late filing |
| Jan 31, 2022 | Late filing | Notification of late filing |
| Jan 12, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Dec 14, 2020 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?